Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Satsuma Pharmaceuticals I...

    NASDAQ: STSA · Real-Time Price · USD
    1.10
    0.00 (0.00%)
    At close: Jun 07, 2023, 10:00 PM

    Satsuma Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a
    Cost of Revenue
    		 n/a n/a
    Gross Profit
    		 n/a n/a
    Operating Income
    		 -70.95M -51.17M
    Interest Income
    		 905K 157K
    Pretax Income
    		 -70.06M -51.17M
    Net Income
    		 -69.16M -51.26M
    Selling & General & Admin
    		 15.13M 13.53M
    Research & Development
    		 44.09M 37.63M
    Other Expenses
    		 n/a n/a
    Operating Expenses
    		 59.22M 51.17M
    Interest Expense
    		 13K 163K
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 59.22M 51.17M
    Income Tax Expense
    		 -892K 92K
    Shares Outstanding (Basic)
    		 32.02M 29.17M
    Shares Outstanding (Diluted)
    		 32.02M 29.17M
    EPS (Basic)
    		 -2.16 -1.76
    EPS (Diluted)
    		 -2.16 -1.76
    EBITDA
    		 -58.31M -50.62M
    EBIT
    		 -70.04M -51.01M
    Depreciation & Amortization
    		 12.63M 550K

    Add to Watchlist